DAVID SANCHEZ: Open Payments
NPI 1992750004 · FOWLER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$649 in 21 payments from 9 companies in 2025. Trend: 2023 $615 · 2024 $1,086 · 2025 $649
Food & beverage: $649
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 8 | $431 |
| PFIZER INC. | 3 | $50 |
| LEO Pharma Inc. | 2 | $45 |
| Arcutis Biotherapeutics, Inc. | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $21 |
| Galderma Laboratories, L.P. | 1 | $17 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $14 |
| Amgen Inc. | 1 | $10 |
Products named: Bimzelx, CIBINQO, ADBRY, Zoryve, DUPIXENT, ILUMYA, NEMLUVIO, OTEZLA.
Industry payments across CA — which companies pay providers there.
